Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Operations (2016 - 2025)

Biomerica's Cash from Operations history spans 16 years, with the latest figure at 991000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 25.28% year-over-year to 991000.0; the TTM value through Nov 2025 reached 2965000.0, up 40.46%, while the annual FY2025 figure was 3841000.0, 28.35% up from the prior year.
  • Cash from Operations for Q4 2025 was 991000.0 at Biomerica, down from 268000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2358296.0 in Q1 2022 and bottomed at 4256046.0 in Q2 2022.
  • The 5-year median for Cash from Operations is 1025842.0 (2021), against an average of 939276.5.
  • The largest YoY upside for Cash from Operations was 272.92% in 2022 against a maximum downside of 2174.21% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 1342914.0 in 2021, then tumbled by 190.33% to 1213000.0 in 2022, then skyrocketed by 30.59% to 842000.0 in 2023, then rose by 6.06% to 791000.0 in 2024, then dropped by 25.28% to 991000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Cash from Operations are 991000.0 (Q4 2025), 268000.0 (Q3 2025), and 661000.0 (Q2 2025).